Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,811 | 14,555 | 38,829 | 12,596 | 129,258 |
| Marketable Securities | 37,753 | 37,932 | 12,086 | 82,438 | 0 |
| Receivables | 2,444 | 188 | 3,000 | N/A | N/A |
| TOTAL | $55,737 | $53,099 | $56,292 | $97,742 | $132,390 |
| Non-Current Assets | |||||
| PPE Net | 3,533 | 5,741 | 12,339 | 11,322 | 13,157 |
| Intangibles | 0 | 0 | 1,384 | 33,966 | 68,644 |
| Other Non-Current Assets | 4,732 | 5,374 | 9,571 | 8,168 | 9,191 |
| TOTAL | $8,265 | $11,115 | $23,294 | $53,456 | $90,992 |
| Total Assets | $64,002 | $64,214 | $79,586 | $151,198 | $223,382 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,438 | 1,811 | 8,924 | 36,210 | 31,163 |
| Accrued Expenses | 5,985 | 3,991 | 5,585 | 3,410 | 5,543 |
| Other current liabilities | 1 | 204 | 296 | N/A | N/A |
| TOTAL | $13,422 | $7,779 | $16,623 | $41,959 | $38,701 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 1,428 | N/A |
| Deferred Revenues | N/A | N/A | N/A | 296 | 296 |
| aiOther Non-Current Liabilities | 35,754 | 29,674 | 20,595 | 5,260 | 6,251 |
| TOTAL | $35,754 | $29,674 | $20,595 | $6,688 | $6,251 |
| Total Liabilities | $49,176 | $37,453 | $37,218 | $48,647 | $44,952 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,355 | 17,709 | 5,895 | 3,952 | 3,345 |
| Common Shares | 265 | 177 | 1,472 | 961 | 836 |
| Retained earnings | -749,524 | -695,336 | -655,640 | -570,704 | -486,470 |
| Other shareholders' equity | -66 | -129 | -27 | -10 | 0 |
| TOTAL | $14,826 | $26,761 | $42,368 | $102,551 | $178,430 |
| Total Liabilities And Equity | $64,002 | $64,214 | $79,586 | $151,198 | $223,382 |